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ABSTRACT
ObjectiveaaOlfactory and emotional dysfunctions are very common in patients with Parkinson’s disease (PD). Olfaction and 
emotions share common neuroanatomical substrates. Therefore, in this study, we evaluated the association between olfactory and 
emotional dysfunctions in patients with PD.
MethodsaaParkinson’s disease patients who had been assessed for their olfactory function and neuropsychiatric symptoms in-
cluding emotional dysfunction were included. A logistic regression analysis was performed to evaluate the association between 
low olfaction and different neuropsychiatric symptoms.
ResultsaaThe patients with low olfaction (cross cultural smell identification test score ≤ 6) showed a higher prevalence of apathy 
when compared with those with high olfaction, whereas the frequencies of other neuropsychiatric symptoms were comparable 
between the two groups. A multivariate logistic regression analysis revealed that the presence of apathy/indifference [odds ratio 
(OR) = 2.859, p = 0.007], age 70 years or more (OR = 2.281, p = 0.009), and the male gender (OR = 1.916, p = 0.030) were signifi-
cantly associated with low olfaction.
ConclusionsaaOur results demonstrate that apathy/indifference is a unique emotional dysfunction associated with olfactory dys-
function in PD. The findings also suggest that PD patients with low olfaction have a high prevalence of apathy.
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There is much evidence to support a close relationship be-
tween olfaction and emotion.1,2 Certain odors reproducibly in-
duce emotional states, and emotional induction modifies odor 
perception.2 Olfaction and emotion share common neuroana-
tomical substrates, such as the amygdala, hippocampus, insula, 
anterior cingulate cortex, and orbitofrontal cortex.2 Accordingly, 
dysosmia patients often experience depressive mood disorders 
and show a higher level of depressive tendencies when com-
pared with normosmia controls.2-4
Olfactory and emotional dysfunctions, such depression, anxi-
ety and apathy, are very common in patients with Parkinson’s 
disease (PD).5,6 These dysfunctions often present in the premo-
tor phase of PD.7 Lewy bodies are found in the olfactory bulb 
and anterior olfactory nucleus in the PD brain.8 The mechanism 
underlying emotional dysfunction in PD is unclear, although 
dysfunction of the mesocorticolimbic pathway and frontostria-
tal loop has been suggested.9 
Therefore, it is conceivable that olfactory and emotional dys-
functions are closely related in PD, i.e., patients with greater ol-
factory dysfunction may show greater emotional dysfunction. 
Only a few studies have investigated this relationship, and these 
have shown controversial results.10,11 Cramer et al.10 have found 
that olfactory impairment correlated with apathy in PD; howev-
er, Morley et al.11 observed no significant association between 
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olfaction and mood measures. Here we evaluated 
the association between olfactory dysfunction and 
emotional dysfunction in Korean patients with PD.
MATERIALS & METHODS
Subjects
Patients with PD who had undergone both the 
olfactory function test and neuropsychiatric symp-
tom assessment during diagnostic work-up were 
selected, based on the medical records of the Yonsei 
Parkinson Center. PD was diagnosed according to 
the clinical criteria of the UK Brain Bank,12 and the 
patients showing subcortical ischemic change or 
infarction in basal ganglia on brain magnetic reso-
nance imaging were excluded in this study. The in-
formants for assessment of neuropsychiatric symp-
toms were limited to an actual caregiver. The patients 
who had an interval longer than 3 months between 
taking both tests were excluded. Because, in our hos-
pital, olfactory function test was performed as a rou-
tine diagnostic work-up for PD, and neuropsychi-
atric symptom assessment was performed as a part 
of routine cognitive evaluation tests, we did not ob-
tain informed consent for these tests. This study and 
the exemption of informed consent were approved 
by the Ethics committee of our hospital. 
Assessment of olfactory function
The 12-item Cross-Cultural Smell Identification 
Test (CCSIT; Sensonics, Inc., Haddon Heights, NJ, 
USA) was used to assess olfactory function.13 This 
test consists of a booklet containing micro-encap-
sulated odorants, which are released by scratching 
the bottom box with a pencil tip. The subjects were 
required to choose one of four alternatives.
Assessment of emotional dysfunction
The Korean version of the Neuropsychiatric In-
ventory (NPI) was used for assessment of emotion-
al dysfunction.14 For caregiver’s self-administration, 
a modified NPI worksheet was used.15 Experienced 
neuropsychologists supervised the caregivers be-
fore administration, and checked that the work-
sheets were appropriate after administration. The 
caregiver who checked the patient’s neuropsychiatric 
symptoms was a patient’s family member, either a 
spouse or daughter and son, who was living together 
with the patient. The questions in each domain and 
scoring system were identical to the original version 
of NPI.16 
Statistical analysis
The distributions of each variable did not satisfy 
the assumption of normality in spite of a large sam-
ple size; therefore we used non-parametric analyses. 
To evaluate the relationship between CCSIT and 
demographic characteristics, we used the Mann-
Whitney U test and Fisher’s exact test. The associa-
tions between the presence of each symptom of the 
NPI and CCSIT score were explored with Fisher’s 
exact test. Logistic regression analysis was used to 
adjust for potential compounders. The statistical 
analyses were performed using Statistical Package 
for the Social Sciences (SPSS) version 20 (IBM SPSS, 
Armonk, NY, USA) and p-values less than 0.05 were 
considered to be significant.
RESULTS
Two hundred and thirty-one patients (age, 69.2 ± 
8.1 years; 111 men) were included in this study. Ac-
cording to the CCSIT score, we classified the pa-
tients into two groups: low olfaction (LO; CCSIT 
score of ≤ 6) and high olfaction (HO; CCSIT score 
of ≥ 7). One hundred and twenty-two patients be-
longed to the LO group, while 109 patients were in 
the HO group. The demographic data of the two 
groups are shown in Table 1. LO patients were old-
er, experienced PD onset at an older age, and showed 
lower Mini-Mental State Examination (MMSE) 
scores than HO patients. The gender distribution 
was different in the two groups. Symptom duration, 
education level, Beck Depression Inventory score 
and Unified Parkinson’s Disease Rating Scale motor 
score were comparable between groups. 
Table 1. Demographic data of subjects with low and high olfaction
Low olfaction
(n = 122)
High olfaction
(n = 109)
p-value
Age (yrs) 71.2 ± 7.5 67.0 ± 8.3 0.001
Gender distribution (% men) 54.9 40.4 0.034
Onset age (yrs) 68.1 ± 8.4 64.4 ± 9.0 0.001
Symptom duration (yrs) 3.1 ± 3.2 2.6 ± 3.0 0.236
Years of education (yrs) 8.8 ± 5.5 8.1 ± 5.3 0.321
MMSE score 24.9 ± 4.3 26.1 ± 3.5 0.017
BDI score 17.2 ± 10.6 15.9 ± 10.2 0.351
UPDRS motor score 28.2 ± 13.8 26.7 ± 14.3 0.465
Data are expressed as means ± SDs. MMSE: Mini-Mental State Examination, BDI: Beck 
Depression Inventory, UPDRS: Unified Parkinson Disease Rating Scale.
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Neuropsychiatric assessments using the NPI are 
shown in Table 2. LO patients showed significantly 
a higher frequency of apathy when compared with 
HO patients (47.5% and 29.3%, respectively; p < 
0.01), but the frequencies of other neuropsychiatric 
symptoms were comparable between groups. A 
multivariate logistic regression analysis was per-
formed with degree of olfactory dysfunction as the 
dependent variable and age, gender distribution, 
MMSE score, and presence of neuropsychiatric symp-
toms included in the NPI as the independent vari-
ables. This analysis revealed that the presence of apa-
thy/indifference [odds ratio (OR) = 2.859, 95% con-
fidence interval (CI) = 1.337–6.114, p = 0.007), age 
70 years or more (OR = 2.281, 95% CI = 1.233–4.217, 
p = 0.009), and the male gender (OR = 1.916, 95% CI = 
1.065–3.447, p = 0.030) were significantly associat-
ed with the presence of LO (Table 3). 
DISCUSSION
This study showed that the presence of apathy/in-
difference was significantly associated with low ol-
factory function in PD patients. The presence of de-
pression/dysphoria or anxiety was not related with 
the degree of olfactory function. In addition to the 
emotional dysfunction evaluated in this study, age 
as well as older age at PD onset, and the male gender 
was also associated with low olfactory function. The 
association of low olfaction with old age and male 
gender is well-recognized in PD patients as well as in 
the general populations.17,18 The present results sug-
gest that PD patients with low olfaction have a high 
prevalence of apathy.
Cramer et al.10 performed an apathy evaluation 
scale and CCSIT in 70 patients with PD and found 
that patients with a higher apathy scale (i.e., apathet-
ic PD) showed a lower CCSIT score when compared 
with patients with a lower apathy scale (i.e., non-
apathetic PD). In addition, they also observed that 
apathetic patients showed a higher depression score 
when compared with non-apathetic patients, but 
found no correlation between CCSIT score and de-
pression score.10 Although they did not measure any 
other neuropsychiatric symptoms, their results are 
somewhat compatible with the present results. In 
contrast, Morley et al.11 performed various neuro-
psychiatric assessments including depression, anxi-
ety and apathy scales, and cognitive tests in 248 PD 
patients, and demonstrated that there was no sig-
nificant association between olfaction and mood 
measures. However, psychotic symptoms and poor 
cognitive function such as memory and executive 
function were associated with low olfaction.11 Cur-
rently, we are unsure of the reason for the discrep-
ancy between Morley et al.11 and those of the present 
study, in addition to the results of Cramer et al.10 
However, it may be related to different subject pop-
ulations; in this study, patients are at an earlier stage 
of PD and a higher proportion of female. We also use 
different methods for assessing emotional and ol-
factory dysfunction. 
Odors elicit emotion and are linked to emotional 
memory.1 Different odors can elicit individual af-
Table 2. Frequencies of neuropsychiatric symptoms according to the olfactory function
Low olfaction
(n = 122)
High olfaction
(n = 109)
p-value
Delusions 4.9 3.7 0.753
Hallucinations 12.3 9.2 0.527
Agitation/aggression 13.9 12.8 0.849
Depression/dysphoria 40.2 34.9 0.418
Anxiety 22.1 29.4 0.229
Elation/euphoria 1.6 0.9 1.000
Apathy/indifference 47.5 29.4 0.007
Disinhibition 7.4 5.5 0.604
Irritability/lability 20.5 26.6 0.281
Aberrant motor behavior 6.6 1.8 0.107
Sleep and nighttime behavior disorders 28.7 31.2 0.774
Appetite and eating disorders 26.2 20.2 0.350
Data are expressed as %. The analyses were performed with Fisher’s exact test.
Table 3. Logistic regression analysis predicting the presence of low olfaction
Odds
ratio
95% 
confidential interval
p-value
Age ≥ 70 2.281 1.233–4.217 0.009
Male gender 1.916 1.065–3.447 0.030
MMSE score ≤ 26 1.208 0.651–2.243 0.549
NPI
Delusions 1.168 0.186–7.348 0.868
Hallucinations 1.841 0.555–6.101 0.318
Agitation/aggression 0.697 0.238–2.039 0.510
Depression/dysphoria 1.265 0.606–2.641 0.532
Anxiety 0.550 0.239–1.267 0.160
Elation/euphoria 0.309 0.017–5.656 0.428
Apathy/indifference 2.859 1.337–6.114 0.007
Disinhibition 2.065 0.506–8.421 0.312
Irritability/lability 0.553 0.237–1.290 0.171
Aberrant motor behavior 3.475 0.557–21.668 0.182
Sleep and nighttime behavior disorders 0.602 0.273–1.326 0.208
Appetite and eating disorders 1.094 0.476–2.518 0.832
Hosmer and Lemeshow goodness-of-fit test, p = 0.574. MMSE: Mini-Mental State Examina-
tion, NPI: neuropsychiatric inventory.
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fective responses which may be pleasant or unpleas-
ant.1 Olfactory dysfunction in PD develops several 
years or even decades before motor symptoms.19,20 
Reduced olfactory stimulation for a long-period 
might reduce emotional memory as well as emotion-
al responses to the external environment, resulting 
in apathy/indifference to external stimuli. Human 
neuroimaging studies have demonstrated that the 
amygdala and orbitofrontal cortex are activated by 
unpleasant or pleasant odors, consistent with their 
function in emotion.21,22 In addition, hypometabo-
lism in the anterior cingulate and orbitofrontal cor-
tex are associated with apathy in Alzheimer’s dis-
ease.23,24 These reports provide evidence to support 
the relationship between a loss of olfactory function 
and reduced emotional response. Although depres-
sion was often reported to be correlated to apa-
thy,10,25,26 it seems unrelated to olfactory dysfunction 
in PD in the present study, similar to the previous 
study.11 
The MMSE score was lower in patients with low 
olfaction, however logistic regression analysis re-
vealed that it was not associated with low olfaction. 
This result is agreement with that of Morley et al.11 
However, in their result, low olfaction was associat-
ed with the performance in Tower of London test or 
verbal memory task.11 On the other hand, several 
studies showed that apathy was related with cogni-
tive impairment,25 especially frontal/executive dys-
function.27 Taken together, frontal/executive dys-
function might be a possible link between olfactory 
dysfunction and apathy, but further investigations 
are required to clear this association.
Our study has a number of limitations, such as a 
retrospective inclusion of patients and no quantifi-
cation of emotional symptom severity due to the 
narrow range of each symptom scale in the NPI. The 
NPI was originally designed for assessing psychiat-
ric symptom mainly in patients with Alzheimer’s dis-
ease,16 and hence, it may not be suitable for PD. Ol-
factory dysfunction is usually non-progressive once 
motor symptoms develop, while apathy can be pro-
gressive throughout the course of PD.10 Thus, a pro-
spective and longitudinal follow-up study is required 
in the future to evaluate changes in the degree of 
apathy relating to olfactory dysfunction in PD.
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